Diana Widicus
Family Medicine · Rochester, ILNPI 1851471072
Payments from drug & device makers
Across 466 payments — averaging $5589.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$2.3M
- Regeneron$128K
- Novo Nordisk AS$107K
- Lexicon Pharmaceuticals, Inc.$31K
- AstraZeneca$395
- Lilly USA, LLC$127
- plus $1K from 27 others
Across 10 payments — averaging $6463.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$65K
What the payments were for
- Food & beverage$1,691100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 87 | $2,336,435 |
| Regeneron | 68 | $128,246 |
| Novo Nordisk AS | 205 | $106,757 |
| Lexicon Pharmaceuticals, Inc. | 1 | $31,477 |
| AstraZeneca | 22 | $395 |
| Lilly USA, LLC | 9 | $127 |
| AMAG Pharmaceuticals, Inc. | 1 | $112 |
| Abbott | 8 | $109 |
| Boehringer Ingelheim | 8 | $109 |
| Astellas Pharma US Inc | 7 | $108 |
| Esperion Therapeutics, Inc. | 7 | $99 |
| Novo Nordisk | 6 | $85 |
| Pfizer | 6 | $77 |
| Eisai Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $39 |
| Amgen | 2 | $33 |
| AbbVie | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Johnson & Johnson | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Circassia Inc. | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FERAHEME$112
How this compares
$2,604,612 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Rochester
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
- Mary ImigMorton$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.